Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

NAPOLITANO, Mariasanta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.141
EU - Europa 2.338
AS - Asia 1.383
SA - Sud America 288
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 6
Totale 13.203
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.088
IT - Italia 853
SG - Singapore 594
CN - Cina 499
DE - Germania 301
BR - Brasile 261
FI - Finlandia 202
IE - Irlanda 186
GB - Regno Unito 156
SE - Svezia 121
UA - Ucraina 102
RU - Federazione Russa 97
FR - Francia 89
RO - Romania 60
IN - India 48
TR - Turchia 48
HK - Hong Kong 37
NL - Olanda 37
CA - Canada 34
KR - Corea 27
AT - Austria 25
CH - Svizzera 23
BE - Belgio 21
UZ - Uzbekistan 16
IR - Iran 15
PK - Pakistan 14
GR - Grecia 12
MY - Malesia 12
AR - Argentina 10
CZ - Repubblica Ceca 10
ID - Indonesia 9
IQ - Iraq 9
CI - Costa d'Avorio 8
ES - Italia 8
EU - Europa 7
LB - Libano 7
MA - Marocco 7
MX - Messico 7
PL - Polonia 6
CR - Costa Rica 5
NP - Nepal 5
PH - Filippine 5
BD - Bangladesh 4
BG - Bulgaria 4
CL - Cile 4
DK - Danimarca 4
EG - Egitto 4
JP - Giappone 4
KZ - Kazakistan 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AL - Albania 3
AU - Australia 3
CO - Colombia 3
IL - Israele 3
JO - Giordania 3
KE - Kenya 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
RS - Serbia 3
XK - ???statistics.table.value.countryCode.XK??? 3
ZA - Sudafrica 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
HR - Croazia 2
JM - Giamaica 2
LT - Lituania 2
NO - Norvegia 2
PE - Perù 2
PY - Paraguay 2
QA - Qatar 2
SN - Senegal 2
TN - Tunisia 2
VN - Vietnam 2
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
EC - Ecuador 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 13.202
Salva come PNG Salva come JPEG
Città #
Fairfield 1.598
Ashburn 971
Houston 746
Woodbridge 704
Wilmington 615
Seattle 613
Chandler 600
Cambridge 533
Singapore 404
Ann Arbor 292
Medford 192
Dublin 185
Des Moines 178
Altamura 152
Princeton 128
Santa Clara 123
Palermo 114
Nanjing 108
Lawrence 106
San Diego 85
Dearborn 79
Beijing 70
Boardman 61
London 45
Ludwigshafen am Rhein 43
Rome 40
Helsinki 36
Shenyang 35
Jacksonville 32
Nanchang 32
Nuremberg 32
Izmir 31
Council Bluffs 30
Hebei 30
São Paulo 28
Zhengzhou 27
Hong Kong 25
Milan 25
Falls Church 24
Jiaxing 24
Redwood City 24
Columbus 22
Phoenix 22
Tulsa 22
Brussels 21
Ningbo 21
Tianjin 21
New York 20
Frankfurt am Main 18
Jinan 16
Kilburn 16
Seongnam 16
Changsha 15
Los Angeles 15
Saint Petersburg 15
Toronto 15
Lappeenranta 14
Orange 14
San Paolo di Civitate 14
Stockholm 14
Bengaluru 13
Guangzhou 13
Ottawa 13
Rio de Janeiro 12
Central 11
Chicago 11
Dallas 11
Pune 11
San Jose 11
Taizhou 11
The Dalles 11
Biandronno 10
Bremen 10
Brasília 9
Falkenstein 9
Hangzhou 9
Norwalk 9
Tashkent 9
Verona 9
Auburn Hills 8
Kumar 8
Marigliano 8
Marseille 8
Treviso 8
Abidjan 7
Belo Horizonte 7
Catania 7
Gualdo Tadino 7
Venice 7
Vienna 7
Bologna 6
Buffalo 6
Curitiba 6
Jakarta 6
Moscow 6
Shanghai 6
Turin 6
Walnut 6
Wandsworth 6
Washington 6
Totale 9.895
Salva come PNG Salva come JPEG
Nome #
Absolute Lymphocyte Count Is Unrelated to Overall Survival in Newly Diagnosed Elderly Patients with Multiple Myeloma Treated with Immunomodulatory Drugs. 358
Clinical phenotype and response to different lines of therapy in elderly with immune thrombocytopenia: A retrospective study 271
null 231
Peripheral circulating cells with paroxysmal nocturnal haemoglobinuria phenotype after a first episode of cerebral sinus vein thrombosis: Results from a multicentre cross-sectional study 211
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system 201
Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies 198
Hereditary combined deficiency of the vitamin K-dependent clotting factors 184
Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate 175
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: a communication from the Platelet Physiology SSC 173
Patient preferences in the treatment of hemophilia A: impact of storage conditions on product choice 170
Acquired haemophilia in cancer: A systematic and critical literature review 163
Hematopoietic peripheral circulating blood stem cells as an independent marker of good transfusion management in patients with β-thalassemia: results from a preliminary study 162
Clinical course of isolated distal deep vein thrombosis in patients with active cancer: A multicenter cohort study 159
Incidence of venous thromboembolism and use of anticoagulation in hematological malignancies: Critical review of the literature 158
Optimal Duration of Low Molecular Weight Heparin for the Treatment of Cancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study. 153
Immunosenescence and lymphomagenesis 153
Atypical presentations of thrombotic thrombocytopenic purpura in middle-aged women with recurrent cerebral macrovascular thrombosis: a case report 152
Activated prothrombin complex concentrate (FEIBA®) in acquired haemophilia A: a large multicentre Italian study - the FAIR Registry 152
Iron-dependent erythropoiesis in women with excessive menstrual blood losses and women with normal menses 151
Role of clinical and laboratory parameters for treatment choice in patients with inherited FVII deficiency undergoing surgical procedures: evidence from the STER registry 150
Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy 149
A Multicenter Real-Life Study On Anticoagulant Treatment With Direct Oral Anticoagulants In Patients With Ph Negative Myeloproliferative Neoplasms 148
Correlation between FIX genotype and pharmacokinetics of Nonacog alpha according to a multicentre Italian study 147
Management of kidney transplantation in a factor VII-deficient patient: case report. 146
Buffy coat-derived platelets cryopreserved using a new method: Results from a pivotal clinical trial on thrombocytopenic patients with acute leukaemia 146
Buffy coat-derived platelets cryopreserved using a new method: Results from in vitro studies 140
Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogues 139
Replacement therapy for bleeding episodes in factor VII deficiency: A prospective evaluation 137
Tailoring haemophilia A prophylaxis with BAY 81-8973: A case series 136
Combined Point of Care Tools Are Able to Improve Treatment Adherence and Health-Related Quality of Life in Patients with Severe Hemophilia: An Observational Prospective Study 135
Quality of Life in Patients With Cancer Under Prolonged Anticoagulation for High-Risk Deep Vein Thrombosis: a Long-Term Follow-Up 134
Autoantibody Inhibitor Eradication In Acquired Hemophilia Associated with Cancer: a Retrospective Analysis 133
Cancers in Patients with von Willebrand Disease: A Survey from the Italian Association of Haemophilia Centres 132
Genetics and Pathogenetic Role of Inflammasomes in Philadelphia Negative Chronic Myeloproliferative Neoplasms: A Narrative Review 132
Cardio-oncology in multiple myeloma: is it time for a specific focus? 131
Abdominal aortic thrombosis secondary to reactive thrombocytosis in a patient with iron deficiency anemia 130
Hematopoietic Peripheral Circulating Blood Stem Cells As an Independent Marker of Good Transfusion Management in Patients with Beta-Thalassemia 128
Effective Hemostasis During Minor Surgery in a Case of Hereditary Combined Deficiency of Vitamin K-dependent Clotting Factors 127
Replacement therapy in inherited factor VII deficiency: Occurrence of adverse events and relation with surgery 125
Acquired Hemophilia A Associated with Venous Thrombosis and Very High Inhibitor Titer: A Challenging Scenario 123
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency. 122
Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia a in Italy: Characteristics and Clinical Benefits 122
Low dose of aPCC after the initial treatment in acquired haemophilia A is useful to reduce bleeding relapses: Data from the FAIR registry 121
Future directions in acquired hemophilia A 121
Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect. 119
The Prevalence of Chronic Cerebrospinal Venous Insufficiency in Meniere Disease: 24-Month Follow-up after Angioplasty 119
Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis 119
OC-01 - Clinical history of cancer patients with isolated distal deep vein thrombosis: a multicenter cohort study 118
Coronary artery stenosis treatment in aging patients with inherited Factor VII deficiency: Where do we stand? 118
Benign intracranial hypertension associated to blood coagulation derangements 118
Invasive procedures and minor surgery in factor VII deficiency 117
Lymphomas and thyroid: Bridging the gap 117
Emotions and Opinions of Adult Patients with Haemophilia During the COVID-19 (Coronavirus Disease 2019) Pandemic Caused by SARS-CoV-2: A Monocentric Survey 116
Bleeding Management of Uterine Conization Using a Pasteurized FVIII/VWF Concentrate in a Woman Affected by Type 2A von Willebrand Disease 114
Management of Venous ThromboEmbolism in patients with acute leukemia at high bleeding risk: a multicenter study 114
Combined use of antifibrinolytics and activated prothrombin complex concentrate (aPCC) is not related to thromboembolic events in patients with acquired haemophilia A: data from FAIR Registry 113
Can we compare haemophilia carriers with clotting factor deficiency to male patients with mild haemophilia? 111
Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency 111
Antimicorbial prophylaxis in patients with immune thrombocytopenia treated with rituximab:a retrospective analysis 109
The Effect of Fluctuating Temperature on the Stability of Turoctocog Alfa for Hemophilia A 108
Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER 106
Vitamin K-induced modification of coagulation phenotype in VKORC1 homozygous deficiency 106
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review 106
Prophylaxis In Congenital Factor VII Deficiency, Indications, Efficacy and Safety: Results of the STER 103
Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment 103
Cryopreserved platelets: from in vitro thrombin generation potential to in vivo safety 102
Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease 101
Sorafenib as a feasible therapeutic option in haemophiliacs with hepatocellular carcinoma 99
COMPARISON OF CLINICAL AND LABORATORY DATA, INCLUDING JAK-2 46/1 HAPLOTYPE, BETWEEN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS AND POLYCYTHEMIA VERA. 98
Inhibitors to factor VII in congenital factor VII deficiency. 97
Coexistence of Von Willebrand disease and gastrointestinal stromal tumor (G.I.S.T): Case report of a rare and challenge association 96
Replacement Therapy for Minor Surgery and Invasive Procedures in Factor VII Deficiency: The STER Experience 94
Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study 94
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep 93
Subcortical ischaemic changes in young hypertensive patients: frequency, effect on cognitive performance and relationship with markers of endothelial and haemostatic activation 91
Vitamin K deficiency bleeding leading to a diagnosis of Crohn’s Disease 87
Incidence and Management Of Venous Thrombosis In Acute Leukemia: A Multicenter Study 86
Le emergenze emorragiche in ematologia 84
Recombinant FVIII Products (Turoctocog Alfa and Turoctocog Alfa Pegol) Stable Up to 40°C 83
Proposal and validation of a novel quantitative approach (QUEM) for the evaluation of menstrual blood losses. Preliminary implementation for the management of menorrhagia in congenital bleeding disorders. 81
Paroxysmal nocturnal haemoglobinuria: When delay in diagnosis and long therapy occurs 81
Functional In Vitro Studies Of Buffy Coat Pooled Platelets Cryopreserved In Dimethyl-Sulphoxide With a New System 80
Addressing the impact of SARS-CoV-2 infection in persons with congenital bleeding disorders: The Italian MECCOVID-19 study 80
Prolonged anticoagulant treatment in patients with cancer: Where do we stand? 79
Ultrasonography-guided central venous catheterisation in haematological patients with severe thrombocytopenia 78
null 78
Prophylaxis in congenital Fctor VII deficiency:indications, efficacy and safety. Results from the Seven Treatment evaluation registry (STER) 76
Personalized prophylaxis with simoctocog-alfa(human-cl rhFVIII):A real-life experience on children and moderate haemophilia A patients 75
[Haemocoagulative modifications correlated with pregnancy] 74
Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER 73
Pain assessment and management in Italian Haemophilia Centres 72
Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review 70
Anomalie della coagulazione e angiodisplasie 70
Plasma viscosity pattern and erythrocyte aggregation in two patients with congenital afibrinogenemia 70
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management 70
Clinical history of thrombosis before diagnosis of overt myeloproliferative neoplasms in triple negative patients 68
Fostering drug.storage,preparation and treatment modalities improves adherence to treatment with turoctocog-alfa in patients with haemophilia A:results from a short term follow-up 68
JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS 66
Pharmacokinetic of Factor VII 65
Response to Urrego et al 62
Totale 12.135
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.966
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020383 0 0 0 0 0 0 0 0 0 160 163 60
2020/20212.576 100 144 394 299 198 181 294 221 155 247 121 222
2021/20221.627 120 268 72 73 46 80 86 110 179 209 136 248
2022/20232.091 226 409 61 191 215 303 144 192 212 19 76 43
2023/2024980 54 124 95 185 77 145 107 42 21 17 23 90
2024/20251.934 81 278 324 220 93 94 192 200 205 247 0 0
Totale 13.964